This topic contains a solution. Click here to go to the answer

Author Question: Reactive arthritis (formerly known as Reiter syndrome) is described as: A) an arthritis ... (Read 55 times)

penguins

  • Hero Member
  • *****
  • Posts: 903
Reactive arthritis (formerly known as Reiter syndrome) is described as:
 
  A) an arthritis characterized as nongonococcal or gonococcal.
  B) an inflammation-type arthritis that follows GI or genitourinary infection caused by organisms including Chlamydia trachomatis, Shigella flexneri, Campylobacter jejuni and Yersinia enterocolitica.
  C) an inflammation in which laboratory tests for rheumatoid factor and anti-cycliccitrullinated peptides (CCP) are usually elevated in patients.
  D) an inflammation characterized by deterioration of articular cartilage with subsequent findings of reactive new bone at the articular surface.

Question 2

What urine specimen would be obtained in the doctor's office for a routine physical?
 
  A) Clean-catch B) Three-glass collection
  C) Catheterized D) Random



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ptupou85

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

B

Answer to Question 2

D




penguins

  • Member
  • Posts: 903
Reply 2 on: Jun 25, 2018
Wow, this really help


phuda

  • Member
  • Posts: 348
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

There are approximately 3 million unintended pregnancies in the United States each year.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library